Comparative Benchmarking
In the context of the broader market, KALA competes directly with industry leaders such as OVID and ABEO. With a market capitalization of $215.80M, it holds a significant position in the sector. When comparing efficiency, KALA's gross margin of N/A stands against OVID's 100.00% and ABEO's 80.74%. Such benchmarking helps identify whether KALA BIO Inc is trading at a premium or discount relative to its financial performance.
